About: Jacques Turgeon

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jacques Turgeon Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	Forscher (de) researcher (en) 연구원 (ko) investigador (es) chercheur (fr) дослідник (uk) باحت (ary) 研究者 (zh) 研究員 (ja) հետազոտող (hy) onderzoeker (nl)
rdfs:label	Jacques Turgeon (en) Jacques Turgeon (fr) Jacques Turgeon (nl)
skos:prefLabel	Jacques Turgeon (en) Jacques Turgeon (fr) Jacques Turgeon (nl)
name	Jacques Turgeon (en) Jacques Turgeon (fr) Jacques Turgeon (nl)
affiliation	wds:Q95605461-0A1442C5-4744-4877-BE12-4CA45C4D61C3
affiliation	Faculté de pharmacie de l’Université de Montréal
given name	wds:Q95605461-B1FC68B9-B9C5-4B51-AA0D-0EBA3FC00189
given name	Jacques
instance of	wds:Q95605461-C5AEAD1D-9A84-42ED-A97D-033FD2893537
instance of	Homo sapiens
occupation	wds:Q95605461-134FCE66-98D6-4EF2-86B2-25D01DAC1B3C wds:Q95605461-A2871370-3417-4788-9C05-03FB43C59122
VIAF ID	wds:Q95605461-21a39a5e-a02b-43bc-bdf4-96a1b74fdb97
on focus list of Wikimedia project	wds:Q95605461-4ED696A2-CBAC-445F-8754-251A95B3FD92
family name	wds:Q95605461-55D31B16-22D2-42F5-A1F4-DA343EA11D02
Canadiana Name Authority ID	wds:Q95605461-7128F52E-0A62-4F68-9918-D388402409DD
VIAF ID	http://viaf.org/viaf/104787268
occupation	university teacher adjunct professor
VIAF ID	104787268
on focus list of Wikimedia project	WikiProject COVID-19
family name	Turgeon
Canadiana Name Authority ID	ncf10181856
ORCID iD	wds:Q95605461-35D74F98-F140-433D-885C-41997CCFDE22
ORCID iD	https://orcid.org/0000-0002-7978-9280
ORCID iD	0000-0002-7978-9280
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q95605461
is author of	An evaluation of pharmacists' expectations towards pharmacogenomics The ATP-binding cassette transporters and their implication in drug disposition: a special look at the heart Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Lengthening of cardiac repolarization in isolated guinea pigs hearts by sequential or concomitant administration of two IKr blockers Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans Gender-related differences in drug-induced prolongation of cardiac repolarization in prepubertal guinea pigs Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Genetic determinants of response to aspirin: appraisal of 4 candidate genes The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition. Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current Effect of a single dose of ritonavir on the pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered in healthy volunteers Multiple-dose pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered over 21 days with lopinavir-ritonavir in human immunodeficiency virus type 1-infected subjects Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy Evaluating the impact of type 2 diabetes mellitus on CYP450 metabolic activities: protocol for a case-control pharmacokinetic study. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System Metabolic activity and mRNA levels of human cardiac CYP450s involved in drug metabolism Olanzapine prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man. Enantioselective quantification of carvedilol in human plasma by HPLC in heavily medicated heart failure patients QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile Risk of drug-induced Long QT Syndrome associated with the use of repurposed COVID-19 drugs: a systematic review Highly sensitive LC-MS/MS methods for the determination of seven human CYP450 activities using small oral doses of probe-drugs in human. Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly Rosuvastatin blocks hERG current and prolongs cardiac repolarization The Dangers of Polypharmacy in Elderly Patients. Effects of β-blockers and tricyclic antidepressants on the activity of human organic anion transporting polypeptide 1A2 (OATP1A2). Drug-induced long QT syndrome in women: review of current evidence and remaining gaps Domperidone and sudden cardiac death: How much longer should we wait? Medication Risk Mitigation: Coordinating and Collaborating with Health Care Systems, Universities, and Researchers to Facilitate the Design and Execution of Practice-Based Research Impact of glucose concentration on cardiac ventricular repolarization under I Kr/I Ks blocking agents Week-long high-maintenance dose clopidogrel regimen achieves better platelet aggregation inhibition than a standard loading dose before percutaneous coronary intervention: results of a double-blind, randomized clinical trial Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE). Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy Precision medication: An illustrative case series guiding the clinical application of multi-drug interactions and pharmacogenomics Risk assessment of drug-induced Long QT Syndrome for some COVID-19 repurposed drugs Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level Understanding clopidogrel efficacy in the presence of cytochrome P450 polymorphism The pharmacokinetics of ezetimibe Assessment of competitive and mechanism-based inhibition by clarithromycin: use of domperidone as a CYP3A probe-drug substrate and various enzymatic sources including a new cell-based assay with freshly isolated human hepatocytes Tissue Specific Modulation of cyp2c and cyp3a mRNA Levels and Activities by Diet-Induced Obesity in Mice: The Impact of Type 2 Diabetes on Drug Metabolizing Enzymes in Liver and Extra-Hepatic Tissues. Development and validation of probe drug cocktails for the characterization of CYP450-mediated metabolism by human heart microsomes. Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study Drug-induced long QT syndrome and torsade de pointes. Study of Statin- and Loratadine-Induced Muscle Pain Mechanisms Using Human Skeletal Muscle Cells. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care. Opioids, Polypharmacy, and Drug Interactions: A Technological Paradigm Shift Is Needed to Ameliorate the Ongoing Opioid Epidemic Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software